1. Home
  2. PT vs LGVN Comparison

PT vs LGVN Comparison

Compare PT & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pintec Technology Holdings Limited

PT

Pintec Technology Holdings Limited

N/A

Current Price

$0.98

Market Cap

14.7M

Sector

Technology

ML Signal

N/A

Logo Longeveron Inc.

LGVN

Longeveron Inc.

N/A

Current Price

$0.58

Market Cap

17.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PT
LGVN
Founded
2012
2014
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
17.6M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
PT
LGVN
Price
$0.98
$0.58
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.50
AVG Volume (30 Days)
53.3K
436.6K
Earning Date
09-19-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,961,892.00
$1,437,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.20
N/A
52 Week Low
$0.76
$0.53
52 Week High
$1.38
$2.24

Technical Indicators

Market Signals
Indicator
PT
LGVN
Relative Strength Index (RSI) 42.47 40.15
Support Level $0.95 $0.53
Resistance Level $1.06 $0.65
Average True Range (ATR) 0.06 0.05
MACD -0.01 0.00
Stochastic Oscillator 3.19 35.13

Price Performance

Historical Comparison
PT
LGVN

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: